MENU
PEPG
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
PepGen (PEPG) Ownership - Who owns PepGen?
PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases... Show more
Profile
Industry
N/A
Address
321 Harrison Avenue
Phone
+1 781 797-0979
Employees
64
Web
https://www.pepgen.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
42.31M
P/E Ratio
N/A
Total Cash
97.78M
Projected Growth
N/A
Total Debt
18.27M
Revenue
N/A
Risk (Beta)
1.16
Dividend Yield
N/A
Total Cash/Share
2.98
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
PEPG
Capitalization
42.3M
P/E Ratio
N/A
Risk (Beta)
1.16
Dividend Yield
N/A
Total Cash
97.8M
Total Cash/Share
2.98
Total Debt
18.3M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
91.8M
P/B Ratio
0.59
Cash Flow
N/A
Earnings
-3.14
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
3K
Current Ratio
4.95
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-102.93M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-61.10
Shares Held By Institutions
167M
Shares Outstanding - Current
32.8M
Total Liabilities
35.6M
Total Volume MTD
N/A
Value
1
Gain YTD
-65.963
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. PEPG showed earnings on August 07, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
321 Harrison Avenue
Phone
+1 781 797-0979
Employees
64
Web
https://www.pepgen.com